EdgarLookup

SONOCO PRODUCTS CO — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that SONOCO PRODUCTS CO filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Financials Insiders
13.3%
Profit Margin
Net income ÷ revenue
9%
Return on Assets
Net income ÷ assets
2.08x
Debt-to-Equity
Total liabilities ÷ equity
+451.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.52B Feb 26, 2026
FY2024 Dec 31, 2024 $1.36B Feb 28, 2025
FY2024 Sep 29, 2024 $1.35B Feb 28, 2025
FY2024 Jun 30, 2024 $1.28B Feb 28, 2025
FY2024 Mar 31, 2024 $1.31B Feb 28, 2025
FY2024 Dec 31, 2023 $1.34B Feb 28, 2025
FY2024 Oct 1, 2023 $1.38B Feb 28, 2025
FY2024 Jul 2, 2023 $1.34B Feb 28, 2025
FY2024 Apr 2, 2023 $1.39B Feb 28, 2025
FY2024 Dec 31, 2022 $5.86B Feb 28, 2025

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.52B Feb 26, 2026
FY2025 Dec 31, 2024 $5.31B Feb 26, 2026
FY2025 Dec 31, 2023 $5.44B Feb 26, 2026
FY2024 Dec 31, 2022 $5.38B Feb 28, 2025
FY2023 Dec 31, 2021 $5.59B Feb 28, 2024
FY2022 Dec 31, 2020 $5.24B Feb 28, 2023
FY2019 Dec 31, 2019 $1.31B Feb 28, 2020
FY2019 Sep 29, 2019 $1.35B Feb 28, 2020
FY2019 Jun 30, 2019 $1.36B Feb 28, 2020
FY2019 Mar 31, 2019 $1.35B Feb 28, 2020

Revenue (Net Sales)

Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.30B Feb 28, 2018
FY2017 Oct 1, 2017 $1.32B Feb 28, 2018
FY2017 Jul 2, 2017 $1.24B Feb 28, 2018
FY2017 Apr 2, 2017 $1.17B Feb 28, 2018
FY2017 Dec 31, 2016 $1.14B Feb 28, 2018
FY2017 Oct 2, 2016 $1.21B Feb 28, 2018
FY2017 Jul 3, 2016 $1.21B Feb 28, 2018
FY2017 Apr 3, 2016 $1.23B Feb 28, 2018
FY2016 Dec 31, 2015 $1.27B Mar 1, 2017
FY2016 Sep 27, 2015 $1.24B Mar 1, 2017

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.00B Feb 26, 2026
FY2024 Dec 31, 2024 ($42.96M) Feb 28, 2025
FY2024 Sep 29, 2024 $50.92M Feb 28, 2025
FY2024 Jun 30, 2024 $90.81M Feb 28, 2025
FY2024 Mar 31, 2024 $65.18M Feb 28, 2025
FY2024 Dec 31, 2023 $81.24M Feb 28, 2025
FY2024 Oct 1, 2023 $130.75M Feb 28, 2025
FY2024 Jul 2, 2023 $114.65M Feb 28, 2025
FY2024 Apr 2, 2023 $148.32M Feb 28, 2025
FY2024 Dec 31, 2022 $466.44M Feb 28, 2025

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.02B Feb 26, 2026
FY2025 Dec 31, 2024 $326.58M Feb 26, 2026
FY2025 Dec 31, 2023 $589.05M Feb 26, 2026
FY2024 Dec 31, 2022 $563.36M Feb 28, 2025
FY2023 Dec 31, 2021 $486.85M Feb 28, 2024
FY2022 Dec 31, 2020 $357.80M Feb 28, 2023
FY2021 Dec 31, 2019 $467.08M Feb 28, 2022
FY2020 Dec 31, 2018 $437.63M Feb 26, 2021
FY2019 Dec 31, 2017 $412.41M Feb 28, 2020
FY2018 Dec 31, 2016 $504.64M Feb 28, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $11.16B Feb 26, 2026
FY2025 Dec 31, 2024 $12.51B Feb 26, 2026
FY2024 Dec 31, 2023 $7.19B Feb 28, 2025
FY2023 Dec 31, 2022 $7.05B Feb 28, 2024
FY2023 Dec 31, 2021 $5.07B Feb 28, 2024
FY2022 Dec 31, 2020 $5.28B Feb 28, 2023
FY2021 Dec 31, 2019 $5.13B Feb 28, 2022
FY2020 Dec 31, 2018 $4.58B Feb 26, 2021
FY2019 Dec 31, 2017 $4.56B Feb 28, 2020
FY2018 Dec 31, 2016 $3.92B Feb 28, 2019

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.53B Feb 26, 2026
FY2025 Dec 31, 2024 $10.22B Feb 26, 2026
FY2024 Dec 31, 2023 $4.76B Feb 28, 2025

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.61B Feb 26, 2026
FY2025 Dec 31, 2024 $2.27B Feb 26, 2026
FY2024 Dec 31, 2023 $2.42B Feb 28, 2025
FY2023 Dec 31, 2022 $2.07B Feb 28, 2024
FY2022 Dec 31, 2021 $1.84B Feb 28, 2023
FY2021 Dec 31, 2020 $1.90B Feb 28, 2022
FY2020 Dec 31, 2019 $1.80B Feb 26, 2021
FY2019 Dec 31, 2018 $1.76B Feb 28, 2020
FY2018 Dec 31, 2017 $1.71B Feb 28, 2019
FY2017 Dec 31, 2016 $1.53B Feb 28, 2018

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 10 Feb 26, 2026
FY2024 Dec 31, 2024 0 Feb 28, 2025
FY2024 Sep 29, 2024 0 Feb 28, 2025
FY2024 Jun 30, 2024 0 Feb 28, 2025
FY2024 Mar 31, 2024 0 Feb 28, 2025
FY2024 Dec 31, 2023 0 Feb 28, 2025
FY2024 Oct 1, 2023 1 Feb 28, 2025
FY2024 Jul 2, 2023 1 Feb 28, 2025
FY2024 Apr 2, 2023 1 Feb 28, 2025
FY2024 Dec 31, 2022 4 Feb 28, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 10 Feb 26, 2026
FY2024 Dec 31, 2024 0 Feb 28, 2025
FY2024 Sep 29, 2024 0 Feb 28, 2025
FY2024 Jun 30, 2024 0 Feb 28, 2025
FY2024 Mar 31, 2024 0 Feb 28, 2025
FY2024 Dec 31, 2023 0 Feb 28, 2025
FY2024 Oct 1, 2023 1 Feb 28, 2025
FY2024 Jul 2, 2023 1 Feb 28, 2025
FY2024 Apr 2, 2023 1 Feb 28, 2025
FY2024 Dec 31, 2022 4 Feb 28, 2025

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $378.40M Feb 26, 2026
FY2025 Dec 31, 2024 $431.01M Feb 26, 2026
FY2024 Dec 31, 2023 $138.90M Feb 28, 2025
FY2023 Dec 31, 2022 $227.44M Feb 28, 2024
FY2022 Dec 31, 2021 $170.98M Feb 28, 2023
FY2021 Dec 31, 2020 $564.85M Feb 28, 2022
FY2020 Dec 31, 2019 $145.28M Feb 26, 2021
FY2019 Dec 31, 2018 $120.39M Feb 28, 2020
FY2018 Dec 31, 2017 $254.91M Feb 28, 2019
FY2018 Dec 31, 2016 $257.23M Feb 28, 2019

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $1.39B Feb 28, 2019
FY2018 Dec 31, 2017 $1.45B Feb 28, 2019
FY2017 Dec 31, 2016 $1.05B Feb 28, 2018
FY2016 Dec 31, 2015 $1.13B Mar 1, 2017
FY2015 Dec 31, 2014 $1.25B Feb 29, 2016
FY2014 Dec 31, 2013 $981.46M Aug 26, 2015
FY2013 Dec 31, 2012 $1.37B Mar 3, 2014
FY2012 Dec 31, 2011 $1.29B Mar 1, 2013
FY2011 Dec 31, 2010 $620.89M Feb 29, 2012